Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“Both cases with and without cognitive decline were observed (see supplemental file 2); concomitant pathology, including Lewy-bodies and TDP-43 proteinopathy, was variable and included lower stages [15] and phases [89] of AD-related pathology as well as different stages of AGD [76].”
BackgroundStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Grouping comprises types of α-synuclein pathology (stages 1–6, [16]; amygdala-predominant form, atypical distribution of Lewy-related pathology, MSA); TDP-43 pathology (limbic, widespread, typical FTLDTDP); CERAD criteria (no, possible, probable, definite, score A–C; [62]) neurofibrillary degeneration [3, 14, 15], sta…”
BackgroundMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 3×
“It should be noted that in seven cases, inclusion of the phases of Aβ deposition [89] for the evaluation of the neuropathologic level made the classification straightforward.”
BackgroundBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 2×
“Grouping comprises types of α-synuclein pathology (stages 1–6, [16]; amygdala-predominant form, atypical distribution of Lewy-related pathology, MSA); TDP-43 pathology (limbic, widespread, typical FTLDTDP); CERAD criteria (no, possible, probable, definite, score A–C; [62]) neurofibrillary degeneration [3, 14, 15], sta…”
BackgroundHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 3×
“28), the BB stages of neurofibrillary degeneration, CERAD score, and the level of AD-neuropathologic change [64] (for all Spearman correlation, p < 0.”
BackgroundMethodConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
The spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 2×
“A recent comprehensive review of the literature concluded that AD-related neuropathologic alterations are likely significant and that the extent of cognitive impairment parallels the best with the severity of neocortical NFT pathology [69].”
BackgroundMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · cited 1×
“Neuropathological studies have emphasised additional pathological alterations (mixed-type dementia), defined mainly as vascular lesions and/or α-synuclein immunoreactive Lewy-bodies, to be seen in the brains of demented elderly individuals [41, 42, 72, 80, 87].”
BackgroundHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1×
“Since the original paper by Alois Alzheimer [7], silver staining methods revealed that in the majority of elderly individuals with dementia, extracellular plaques, later found to be composed of amyloid-beta (Aβ) peptide (for review see [59]), and intracellular neurofibrillary tangles, later found to be composed of tau…”
BackgroundClassification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
A harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R. A., Neumann, M., Baborie, A., Sampathu, D. M., Du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. Y. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,017
Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 1×
“1 3 It has been hypothesised that Aβ, tau, and α-synuclein mutually promote their accumulation [17, 33].”
BackgroundBarker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 705
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., Holton, J. L., Revesz, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 667
Mollenhauer, B., Locascio, J. J., Schulz-Schaeffer, W., Sixel-Döring, F., Trenkwalder, C., & Schlossmacher, M. G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70014-x · Cited by 622
Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q., & LaFerla, F. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0490-10.2010 · Cited by 576
Conversion from subtypes of mild cognitive impairment to Alzheimer dementia
Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., Krampla, W., & Tragl, K. H. (2007) · Neurology · doi:10.1212/01.wnl.0000252358.03285.9d · Cited by 471
Self-citationAlafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467 · cited 2×
“Grouping comprises types of α-synuclein pathology (stages 1–6, [16]; amygdala-predominant form, atypical distribution of Lewy-related pathology, MSA); TDP-43 pathology (limbic, widespread, typical FTLDTDP); CERAD criteria (no, possible, probable, definite, score A–C; [62]) neurofibrillary degeneration [3, 14, 15], sta…”
BackgroundInfluentialSelf-citationTwo Types of Sporadic Cerebral Amyloid Angiopathy
Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446
Pathological correlates of dementia in a longitudinal, population‐based sample of aging
Sonnen, J. A., Larson, E. B., Crane, P. K., Haneuse, S., Li, G., Schellenberg, G. D., Craft, S., Leverenz, J. B., & Montine, T. J. (2007) · Annals of Neurology · doi:10.1002/ana.21208 · Cited by 432 · cited 2×
“Neuropathological studies have emphasised additional pathological alterations (mixed-type dementia), defined mainly as vascular lesions and/or α-synuclein immunoreactive Lewy-bodies, to be seen in the brains of demented elderly individuals [41, 42, 72, 80, 87].”
BackgroundResultStaging of Argyrophilic Grains: An Age-Associated Tauopathy
Saito, Y., Ruberu, N. N., Sawabe, M., Arai, T., Tanaka, N., Kakuta, Y., Yamanouchi, H., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.911 · Cited by 431
Neuropathology underlying clinical variability in patients with synucleinopathies
Halliday, G. M., Holton, J. L., Revesz, T., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0852-9 · Cited by 430
Whitwell, J. L., Dickson, D. W., Murray, M. E., Weigand, S. D., Tosakulwong, N., Senjem, M. L., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70200-4 · Cited by 419
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0460-5 · Cited by 418
Self-citationWilliams, D. R., Holton, J. L., Strand, C., Pittman, A., de Silva, R., Lees, A. J., & Revesz, T. (2007) · Brain · doi:10.1093/brain/awm104 · Cited by 417
Healthy Aging and Dementia: Findings from the Nun Study
Snowdon, D. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_2-200309021-00014 · Cited by 410
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381 · cited 1×
“These observations further support the concept that the tau-astrogliopathy has a pathogenesis differing from AD [85] and in some cases it may lower the threshold for cognitive impairment.”
BackgroundThe Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P., & Bennett, D. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1227 · Cited by 372
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2176 · Cited by 339
Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · cited 3×
“According to our study, the presence of neuritic plaques should not be interpreted as irrelevant as suggested also by others [70].”
BackgroundInfluentialHippocampal sclerosis in advanced age: clinical and pathological features
Nelson, P. T., Schmitt, F. A., Lin, Y., Abner, E. L., Jicha, G. A., Patel, E., Thomason, P. C., Neltner, J. H., Smith, C. D., Santacruz, K. S., et al. (2011) · Brain · doi:10.1093/brain/awr053 · Cited by 279 · cited 1×
“Indeed, we also confirm a recent observation that hippocampus sclerosis is significantly associated with TDP-43 immunoreactive structures [71].”
ResultCognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
Schneider, J. A., Arvanitakis, Z., Yu, L., Boyle, P. A., Leurgans, S. E., & Bennett, D. A. (2012) · Brain · doi:10.1093/brain/aws234 · Cited by 273 · cited 1×
“In contrast to others [74], we found that α-synuclein pathology may also have an impact on cognitive decline, as reported by others [81, 87].”
ResultFerrer, I., Santpere, G., & van Leeuwen, F. W. (2008) · Brain · doi:10.1093/brain/awm305 · Cited by 254
Nelson, P. T., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Davis, D. G., Poduska, J. W., Patel, E., Mendiondo, M. S., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00244.x · Cited by 239
Jack, C. R., Barkhof, F., Bernstein, M. A., Cantillon, M., Cole, P. E., DeCarli, C., Dubois, B., Duchesne, S., Fox, N. C., Frisoni, G. B., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.04.007 · Cited by 220
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Kasai, T., Tokuda, T., Ishigami, N., Sasayama, H., Foulds, P., Mitchell, D. J., Mann, D. M. A., Allsop, D., & Nakagawa, M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0456-1 · Cited by 211
The significance of medial temporal lobe atrophy: A postmortem MRI study in the very old
Barkhof, F., Polvikoski, T. M., van Straaten, E. C. W., Kalaria, R. N., Sulkava, R., Aronen, H. J., Niinistö, L., Rastas, S., Oinas, M., Scheltens, P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000277459.83543.99 · Cited by 204 · cited 1×
“1 3 various disorders with overlapping clinical presentations [11, 19], and we also show that TDP-43 pathology or nonAD tauopathies may associate with medial temporal lobe atrophy.”
BackgroundIncidental Lewy Body Disease and Preclinical Parkinson Disease
DelleDonne, A., Klos, K. J., Fujishiro, H., Ahmed, Z., Parisi, J. E., Josephs, K. A., Frigerio, R., Burnett, M., Wszolek, Z. K., Uitti, R. J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1074 · Cited by 197
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161560 · Cited by 186 · cited 1×
“Mixed pathologies were described in differing cohorts with distinct strategies for recruiting and selecting brain samples and not only in AD, but also in other brain disorders [10, 47].”
BackgroundSelf-citationJellinger, K. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.09.002 · Cited by 179
Kovacs, G. G., Wagner, U., Dumont, B., Pikkarainen, M., Osman, A. A., Streichenberger, N., Leisser, I., Verchère, J., Baron, T., Alafuzoff, I., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0964-x · Cited by 169
Self-citationSubgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
Iqbal, K., Flory, M., Khatoon, S., Soininen, H., Pirttila, T., Lehtovirta, M., Alafuzoff, I., Blennow, K., Andreasen, N., Vanmechelen, E., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20639 · Cited by 163
Kovács, G. G., Majtényi, K., Spina, S., Murrell, J. R., Gelpí, E., Höftberger, R., Fraser, G. M., Crowther, R. A., Goedert, M., Budka, H., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318187a80f · Cited by 134
Self-citationTau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
Forman, M. S., Schmidt, M. L., Kasturi, S. S., Perl, D. P., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61119-4 · Cited by 133
Dawe, R. J., Bennett, D. A., Schneider, J. A., & Arfanakis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026286 · Cited by 123
Kovács, G. G., Seguin, J., Quadrio, I., Höftberger, R., Kapás, I., Streichenberger, N., Biacabé, A.-G., Meyronet, D., Sciot, R., Vandenberghe, R. R., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0713-y · Cited by 123
Self-citationGeser, F., Robinson, J. L., Malunda, J. A., Xie, S. X., Clark, C. M., Kwong, L. K., Moberg, P. J., Moore, E. M., Deerlin, V. M. V., Lee, V. M. ‐., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.254 · Cited by 118
Alafuzoff, I., Pikkarainen, M., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Ferrer, I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229986.17548.27 · Cited by 117
Self-citationProtein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 110
Self-citationAlafuzoff, I. I., Pikkarainen, M., Arzberger, T., Thal, D. R., Al‐Sarraj, S., Bell, J. E., Bódi, I., Budka, H., Capetillo‐Zarate, E., Ferrer, I., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0358-2 · Cited by 107
Self-citationMorphological substrates of cognitive decline in nonagenarians and centenarians: A new paradigm?
Imhof, A., Kövari, E., von Gunten, A., Gold, G., Rivara, C.-B., Herrmann, F. R., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.025 · Cited by 106
Foulds, P. G., Davidson, Y. S., Mishra, M., Hobson, D. J., Humphreys, K. M., Taylor, M., Johnson, N., Weıntraub, S., Akiyama, H., Arai, T., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0594-0 · Cited by 105
Arnold, S. J., Dugger, B. N., & Beach, T. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1110-0 · Cited by 103
Argyrophilic grains: A distinct disease or an additive pathology?
Josephs, K. A., Whitwell, J. L., Parisi, J. E., Knopman, D. S., Boeve, B. F., Geda, Y. E., Jack, C. R., Petersen, R. C., & Dickson, D. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.032 · Cited by 101
FUS‐Immunoreactive Intranuclear Inclusions in Neurodegenerative Disease
Woulfe, J., Gray, D. A., & Mackenzie, I. R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00337.x · Cited by 100
A presenilin 1 mutation in the first case of Alzheimer's disease
Müller, U., Winter, P., & Graeber, M. B. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70307-1 · Cited by 100
High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe
Schultz, C., Ghebremedhin, E., Tredici, K. D., Rüb, U., & Braak, H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00113-1 · Cited by 94
A peculiar constellation of tau pathology defines a subset of dementia in the elderly
Kovács, G. G., Molnár, K., László, L., Ströbel, T., Botond, G., Hönigschnabl, S., Reiner‐Concin, A., Palkovits, M., Fischer, P. A., & Budka, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0819-x · Cited by 93
Self-citationHippocampal Sclerosis Dementia with Tauopathy
Beach, T. G., Sue, L. I., Scott, S., Layne, K. J., Newell, A., Walker, D. G., Baker, M., Sahara, N., Yen, S.-H. C., Hutton, M. L., et al. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00027.x · Cited by 93
Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
Alafuzoff, I., Parkkinen, L., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Ferrer, I., Gelpi, E., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181633526 · Cited by 90
Self-citationNeocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
Robinson, J. L., Geser, F., Corrada, M. M., Berlau, D. J., Arnold, S. E., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2011) · Brain · doi:10.1093/brain/awr308 · Cited by 88
Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases
Kovacs, G. G., & Budka, H. (2010) · Clinical Neuropathology · doi:10.5414/npp29271 · Cited by 85
Self-citationBigio, E. H., Mishra, M., Hatanpaa, K. J., White, C. L., Johnson, N., RADEMAKER, A. W., Weitner, B. B., Deng, H., Dubner, S., Weıntraub, S., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0681-2 · Cited by 84
Kovács, G. G., Rozemüller, A. J. M., Swieten, J. C. V., Gelpí, E., Majtényi, K., Al‐Sarraj, S., Troakes, C., Bódi, I., King, A., Hortobágyi, T., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01272.x · Cited by 81
Self-citationAhmed, Z., Doherty, K. A., Silveira‐Moriyama, L., Bandopadhyay, R., Lashley, T., Mamais, A., Hondhamuni, G., Wray, S., Newcombe, J., O’Sullivan, S. S., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0857-4 · Cited by 79
Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation
Fischer, P. A., Jungwirth, S., Krampla, W. W., Weissgram, S., Kirchmeyr, W., Schreiber, W., Huber, K., Rainer, M., Bauer, P., & Tragl, K. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_11 · Cited by 70
Self-citationFrontotemporal Dementia in Elderly Individuals
Baborie, A., Griffiths, T. D., Jaros, E., Momeni, P., McKeith, I. G., Burn, D. J., Keir, G., Larner, A. J., Mann, D. M. A., & Perry, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3323 · Cited by 66
Iseki, E., Marui, W., Kosaka, K., & Uéda, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00178-0 · Cited by 65
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0466-z · Cited by 60
Santpere, G., & Ferrer, I. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00173.x · Cited by 59
Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
Evidente, V. G. H., Adler, C. H., Sabbagh, M. N., Connor, D. J., Hentz, J. G., Caviness, J. N., Sue, L. I., & Beach, T. G. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.017 · Cited by 53
Mesial Temporal Astrocyte Tau Pathology in the MRC-CFAS Ageing Brain Cohort
Lace, G., Ince, P. G., Brayne, C., Savva, G. M., Matthews, F. E., de Silva, R., Simpson, J. E., & Wharton, S. B. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341581 · Cited by 52 · cited 3×
“1 3 in the mesial temporal lobe [56, 82], the sole presence of these astrocytes was not considered as “tauopathies” in the present series.”
BackgroundCorrelation of Clinical Features With Argyrophilic Grains at Autopsy
Sabbagh, M. N., Sandhu, S. S., Farlow, M. R., Vedders, L., Shill, H. A., Caviness, J. N., Connor, D. J., Sue, L., Adler, C. H., & Beach, T. G. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318199d833 · Cited by 51
Co-occurrence of Different Pathologies in Dementia: Implications for Dementia Diagnosis
Echávarri, C., Burgmans, S., Caballero, M. C., Garcia-Bragado, F., Verhey, F. R. J., & Uylings, H. B. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111400 · Cited by 48
Abundant glial α-synuclein pathology in a case without overt clinical symptoms
Parkkinen, L., Hartikainen, P. H., & Alafuzoff, I. I. (2007) · Clinical Neuropathology · doi:10.5414/npp26276 · Cited by 39
Xekardaki, A., Santos, M., Hof, P. R., Kövari, E., Bouras, C., & Giannakopoulos, P. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1021-5 · Cited by 36
Mori, F., Tanji, K., Kon, T., Odagiri, S., Hattori, M., Hoshikawa, Y., Kono, C., Yasui, K., Yokoi, S., Hasegawa, Y., et al. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01217.x · Cited by 31
Pathways to the discovery of the Aβ amyloid of Alzheimer's disease
Masters, C. L., & Beyreuther, K. T. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s318 · Cited by 30
Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy
Clippinger, A. K., D’Alton, S., Lin, W.-L., Gendron, T. F., Howard, J. C., Borchelt, D., Cannon, A. D., Carlomagno, Y., Chakrabarty, P., Cook, C. N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1123-8 · Cited by 29
Ádori, C., Kovács, G. G., Lőw, P., Molnár, K., Gorbea, C. M., Fellinger, E., Budka, H., Mayer, R. J., & László, L. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.015 · Cited by 29
Self-citationIncidental corticobasal degeneration in a 76-year-old woman
Milenković, I., & Kovács, G. G. (2012) · Clinical Neuropathology · doi:10.5414/np300515 · Cited by 23
Silveira‐Moriyama, L., Gonzalez, A. M. D., O’Sullivan, S. S., Williams, D. R., Massey, L. A., Parkkinen, L., Ahmed, Z., de Silva, R., Chacón, J., Révész, T., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.036 · Cited by 22
Clinical stratification of subtypes of Alzheimer's disease
Kovács, G. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70209-0 · Cited by 19
VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly
Fischer, P. A., Krampla, W. W., Mostafaie, N., Zehetmayer, S., Rainer, M., Jungwirth, S., Huber, K., Bauer, K., Hruby, W., Riederer, P. F., et al. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_23 · Cited by 16
Self-citationKapás, I., Katkó, M., Harangi, M., Paragh, G., Balogh, I., Kóczi, Z., Regelsberger, G., Molnár, M. J., & Kovács, G. G. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12058 · Cited by 16
Echávarri, C., Caballero, M. C., Aramendía, A., García‐Bragado, F., & Tuñón, T. (2011) · The Anatomical Record · doi:10.1002/ar.21413 · Cited by 14
Globular glial-like inclusions in a patient with advanced Alzheimer’s disease
Gelpí, E., Cullel, F., Navarro‐Otano, J., & Lladó, A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1131-8 · Cited by 11
Cited by
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
“This is particularly so in elderly individuals where comorbidities are common [92].”
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
“Tau-immunoreactive glial pathology is also frequently seen in advanced old age [1, 44, 65, 68, 89, 90, 127].”
Background
Metadata
- Authors
- Kovacs, G. G., Milenkovic, I., Wöhrer, A., Höftberger, R., Gelpi, E., Haberler, C., Hönigschnabl, S., Reiner-Concin, A., Heinzl, H., Jungwirth, S., Krampla, W., Fischer, P., & Budka, H.
- Venue
- Acta Neuropathologica
- Published
- 2013-07-31
- Volume
- 126
- Issue
- 3
- Pages
- 365-384
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1979060890
- Cited by
- 361
- References
- 94
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.